000 05338nam a22005895i 4500
001 978-3-031-62007-2
003 DE-He213
005 20251030113324.0
007 cr nn 008mamaa
008 241124s2024 sz | s |||| 0|eng d
020 _a9783031620072
_9978-3-031-62007-2
024 7 _a10.1007/978-3-031-62007-2
_2doi
050 4 _aTA418.95-455.2
072 7 _aTGM
_2bicssc
072 7 _aTEC021000
_2bisacsh
072 7 _aTGML
_2thema
245 1 0 _aBioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry
_h[electronic resource] :
_bUsing Chemistry and Bioengineering to Improve the Performance of Biologics /
_cedited by Kumar Gadamasetti, Stephen A. Kolodziej.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXXIV, 559 p. 129 illus., 105 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aBioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry Using Chemistry and Bioengineering to Improve the Performance of Biologics An Overview -- Synthetic Biology in Drug Development and Beyond -- Increasing the Scalability of DNA Synthesis and Its Key Role in Expanding the Biopharmaceutical Discovery Process -- Advancements in the Manufacture of Monoclonal Antibodies and other Large Molecule Protein Therapeutics Recent Innovations in Cell Culture Technology Enabling Process Intensification -- Process Development and Manufacturing Considerations for Multispecific (Bispecific and Trispecific) Antibodies Case Studies -- Metabolic and process engineering to control glycan structures for biopharmaceuticals produced in cultured mammalian cells -- Even A Worm Will Turn Immunity Following AAV Vector Administration -- COVID-19 Vaccine Manufacturing Processes Making the Molecules to Solve the Pandemic -- CAR T Bioprocessing -- CRISPR Technology and its Application in Therapeutics -- Fusion Proteins Current Status and Future Perspectives -- Development of Antibody Drug Conjugates -- Mylotarg The Journey to FDA Reapproval and Broad International Approval -- Biopharmaceutical Informatics A Strategic Vision for Discovering Developable Biotherapeutic Drug Candidates -- Advanced Data Analytics Application in Bio manufacturing Processes -- Overview of Complexities of Global CMC Regulatory Affairs -- CMC Considerations for Continuous Bioprocess Design, Development and Manufacturing -- Three Decades of Advancements in Technical Transfer of Biologics a Blueprint for Advanced Therapeutics -- Emerging Biopharmaceutical Technologies and Trends.
520 _aThis book outlines how advances in the diverse scientific and engineering disciplines of synthetic biology, DNA synthesis, production of protein therapeutics, and bioinformatics have led to the commercialization of new complex biotherapeutic modalities in modern era, including monoclonal and multi-specific antibodies, antibody drug conjugates (ADC), fusion proteins, CAR-T and CRISPR technologies and applications, mRNA vaccines and more. Enabling operations to bring these life-changing medicines into the hands of the needy patients include regulatory submissions to authorities across the globe, as well as streamlined production across manufacturing networks deemed necessary and are outlined in dedicated chapters. Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics captures the state of the art for many of these new modalities, offering innovative approaches to treat, prevent, and in some providential cases, cure the disease. This book will be of significant interest for many disciplines engaged jointly as teams convergently in delivering these medicines: bioprocess engineers, biologists, chemists, bioengineers, genetic engineers, healthcare professionals, regulatory bodies, among pharmaceutical industry professionals as well as in academic circles.
650 0 _aBiomaterials.
650 0 _aBiomedical engineering.
650 0 _aBiotechnology.
_965162
650 0 _aPharmaceutical chemistry.
_967843
650 0 _aGreen chemistry.
_965085
650 1 4 _aBiomaterials.
650 2 4 _aBiomedical Engineering and Bioengineering.
650 2 4 _aBiotechnology.
_965162
650 2 4 _aPharmaceutics.
_967846
650 2 4 _aBiotechnology.
_965162
650 2 4 _aGreen Chemistry.
_965085
700 1 _aGadamasetti, Kumar.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_987946
700 1 _aKolodziej, Stephen A.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_987947
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031620065
776 0 8 _iPrinted edition:
_z9783031620089
776 0 8 _iPrinted edition:
_z9783031620096
856 4 0 _uhttps://doi.org/10.1007/978-3-031-62007-2
912 _aZDB-2-CMS
912 _aZDB-2-SXC
999 _c65161
_d65161